/ SuspendedNot Applicable A First in Human (FIH) Study to Assess the Safety and Feasibility of the Bio-electrical One Day Capsule (ODC) System (Type 1 and 2 Capsules) in Overweight and Class 1 Obese Subjects
The study represents the first effort to prospectively investigate the Melcap's bio-electrical ingestible ODC system in human. The study goal is to evaluate the safety and feasibility of GES treatment in stomach and in the small and large bowel during and following the ingestion of the bio-electrical capsule under tight and controlled conditions.
100 Clinical Results associated with Melcap Systems Ltd.
0 Patents (Medical) associated with Melcap Systems Ltd.
100 Deals associated with Melcap Systems Ltd.
100 Translational Medicine associated with Melcap Systems Ltd.